Marathon Capital Management Astrazeneca PLC Transaction History
Marathon Capital Management
- $414 Million
- Q3 2025
A detailed history of Marathon Capital Management transactions in Astrazeneca PLC stock. As of the latest transaction made, Marathon Capital Management holds 160,955 shares of AZN stock, worth $14.4 Million. This represents 2.98% of its overall portfolio holdings.
Number of Shares
160,955
Previous 163,405
1.5%
Holding current value
$14.4 Million
Previous $11.4 Million
8.15%
% of portfolio
2.98%
Previous 3.03%
Shares
8 transactions
Others Institutions Holding AZN
# of Institutions
1,543Shares Held
503MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...